Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Iradimed stock (IRMD)

Buy Iradimed stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Iradimed is a medical devices business based in the US. Iradimed shares (IRMD) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $52.30 – a decrease of 2.61% over the previous week. Iradimed employs 160 staff and has a trailing 12-month revenue of around $73.2 million.

Our top picks for where to buy Iradimed stock

Top pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you open and fund a new account within 30 days
  • Access to a financial planner
Customer must fund their Active Invest account with at least $50 within 30 days of opening the account. Probability of customer receiving $1,000 is 0.028%. See full terms and conditions.

Top pick for best mobile experience

Go to site
  • Trade $0 commission stocks, ETFs, futures and options with as little as $1
  • After-hours trading available
  • Earn 4% interest on uninvested cash with Gold
  • 24/7 customer support

Top pick for advanced trading tools

Go to site
  • Trade stocks, options, futures, currencies, crypto, precious metals and more
  • Mobile, browser and desktop trading platforms
  • Earn 3.83% APY on your uninvested cash

How to buy Iradimed stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – IRMD. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Iradimed stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Product Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.01%
Get up to $1,000 in stock
Trade stocks, ETFs, and options with zero commissions, invest in IPOs or automate your portfolio, with exclusive perks available through SoFi Plus.
Finder score
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex, Treasury Bills, Precious metals
$0
$0
3.83% Lite
4.83% Pro
N/A
Trade a wide range of assets, with global market access and pro-grade trading tools.
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, High-yield cash account
$0
$0
4%
Get a free stock
Trade stocks, options, crypto and more, with advanced trading tools, fractional shares and exclusive perks for Gold members.
eToro logo
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, Investments
$0
$0
3.9%
N/A
No commission stock, ETF and options trades, with 3.9% interest on your options account balance and no options contract fees. See full disclosure.
OPTO logo
Finder score
Stocks, ETFs
$0
$0
4%
Earn up to $300
Copy top-performing portfolios or build your own stock index on Opto's AI-driven thematic investing platform, and get 4% APY on your cash.
loading

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Iradimed stock price (NASDAQ: IRMD)

Use our graph to track the performance of IRMD stocks over time.

Iradimed shares at a glance

Information last updated 2025-05-04.
Latest market close$52.30
52-week range$41.22 - $63.10
50-day moving average $52.61
200-day moving average $51.98
Wall St. target price$71.00
PE ratio 35.6467
Dividend yield $0.47 (1.27%)
Earnings per share (TTM) $1.50

Is it a good time to buy Iradimed stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Iradimed price performance over time

Historical closes compared with the close of $53.47 from 2025-05-02

1 week (2025-04-28) 0.85%
1 month (2025-04-04) 7.11%
3 months (2025-02-06) -12.86%
6 months (2024-11-06) -4.86%
1 year (2024-05-06) 22.67%
2 years (2023-05-05) 17.29%
3 years (2022-05-05) 73.40%
5 years (2020-05-06) 192.72%

Is Iradimed stock undervalued or overvalued?

Valuing Iradimed stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Iradimed's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Iradimed's P/E ratio

Iradimed's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 36x. In other words, Iradimed shares trade at around 36x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Iradimed's PEG ratio

Iradimed's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.46. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Iradimed's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Iradimed's EBITDA

Iradimed's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $22.8 million.

The EBITDA is a measure of a Iradimed's overall financial performance and is widely used to measure a its profitability.

Iradimed financials

Revenue TTM $73.2 million
Operating margin TTM 29.92%
Gross profit TTM $56.3 million
Return on assets TTM 14.41%
Return on equity TTM 24.31%
Profit margin 26.26%
Book value $6.83
Market Capitalization $679.9 million

TTM: trailing 12 months

Iradimed share dividends

48%

Dividend payout ratio: 48.06% of net profits

Recently Iradimed has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Iradimed shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Iradimed's case, that would currently equate to about $0.47 per share.

While Iradimed's payout ratio might seem fairly standard, it's worth remembering that Iradimed may be investing much of the rest of its net profits in future growth.

Iradimed's most recent dividend payout was on 4 March 2025. The latest dividend was paid out to all shareholders who bought their shares by 23 February 2025 (the "ex-dividend date").

Iradimed share price volatility

Over the last 12 months, Iradimed's shares have ranged in value from as little as $41.2197 up to $63.0987. A popular way to gauge a stock's volatility is its "beta".

IRMD.US volatility(beta: 0.83)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Iradimed's is 0.834. This would suggest that Iradimed's shares are less volatile than average (for this exchange).

Iradimed overview

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida. .

Frequently asked questions

What percentage of Iradimed is owned by insiders or institutions?
Currently 36.798% of Iradimed shares are held by insiders and 58.655% by institutions.
How many people work for Iradimed?
Latest data suggests 160 work at Iradimed.
When does the fiscal year end for Iradimed?
Iradimed's fiscal year ends in December.
Where is Iradimed based?
Iradimed's address is: 1025 Willa Springs Drive, Winter Springs, FL, United States, 32708
What is Iradimed's ISIN number?
Iradimed's international securities identification number is: US46266A1097
What is Iradimed's CUSIP number?
Iradimed's Committee on Uniform Securities Identification Procedures number is: 46266A109

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

More guides on Finder

Go to site